Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Anthem $2.5 billion senior notes offering
Davis Polk advised the representatives of the several underwriters on an SEC-registered offering by Anthem, Inc. of $2.5 billion in aggregate principal amount of senior notes, consisting of…
Eli Lilly $1 billion notes offering
Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.0 billion aggregate principal amount of its 2.250% notes due 2050…
Fifth Third Bancorp $1.25 billion debt offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering of $500 million aggregate principal amount of 1.625% senior notes due 2023 and $750 million…
Lam Research $2 billion notes offering
Davis Polk advised the joint book-running managers in connection with a $2 billion SEC-registered notes offering by Lam Research Corporation, consisting of $750 million aggregate…
Texas Instruments $750 million notes offering
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 1.750% notes due 2030. Texas Instruments designs and…
Baker Hughes $500 million notes offering
Davis Polk advised Baker Hughes, a GE company, LLC and Baker Hughes Co-Obligor, Inc. on their $500 million SEC-registered debt offering of 4.486% notes due 2030.  Baker Hughes is an…
DuPont de Nemours $2 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by DuPont de Nemours, Inc. of $2 billion aggregate principal amount of…
Biogen $3 billion senior notes offering
Davis Polk advised the representatives of the underwriters, in connection with the SEC-registered offering by Biogen Inc. of $1.5 billion principal amount of 2.250% senior notes due 2030…
Back to top